Learn the symptoms, treatment for early and refractory relapse and prognosis. There are many treatment options for relapsed or refractory multiple myeloma (mm) With the introduction of several new agents, myeloma treatment has changed drastically, and there are new options for the management of relapsed or refractory disease, including new drug classes with distinct mechanisms of action and cellular therapies.
Allison Cactus Net Worth 2022| Age, Onlyfan, And Instagram - The Famous
Multiple myeloma is an incurable hematological malignancy, but recent advances in the treatment have improved the survival outcomes in patients
Despite treatment, multiple myeloma patients are at high risk of relapse and need prompt treatment to reduce the morbidity and mortality associated with the disease and its complications.
Learn the symptoms, causes, and treatment for. The treatment of relapsed/refractory multiple myeloma (mm) has evolved to include several new options These include new combinations with second generation proteasome inhibitors (pi) Second generation immunomodulators, monoclonal antibodies, car t cells, bispecific antibodies, selinexor, venetoclax, and many others
Most patients with mm undergo several cycles of remissions and relapse, and. This may include repeating the treatment used in your induction therapy or trying different therapies from the same class of treatment as those used for induction. Treatments for relapsed or refractory multiple myeloma include targeted therapy, stem cell transplant, watchful waiting, immunotherapy, radiation therapy and supportive therapy. This array of choices leads to complexity in designing an optimal regimen for a patient with relapsed myeloma
Herein, we discuss treatment of early relapse.
Recurrences in multiple myeloma require tailored treatment approaches Explore your options for early relapse and stay informed about potential therapies.
